These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20975529)

  • 1. A novel approach to noninferiority testing: documented proof rather than arbitrary margins.
    Cleophas TJ; Zwinderman AH
    Am J Ther; 2012 Mar; 19(2):101-7. PubMed ID: 20975529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed noninferiority margin and statistical tests in active controlled trials.
    Tsou HH; Hsiao CF; Chow SC; Yue L; Xu Y; Lee S
    J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Making sense of noninferiority: a clinical and statistical perspective on its application to cardiovascular clinical trials.
    Kaul S; Diamond GA
    Prog Cardiovasc Dis; 2007; 49(4):284-99. PubMed ID: 17185116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the response rates for superiority, noninferiority and equivalence testing with multiple-to-one matched binary data.
    Tsong Y; Yuan M; Dong X; Wu YT; Shen M
    J Biopharm Stat; 2013; 23(1):98-109. PubMed ID: 23331224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choice of delta noninferiority margin and dependency of the noninferiority trials.
    Tsong Y; Zhang J; Levenson M
    J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo or active control trials of antipsychotic drugs?
    Fleischhacker WW; Czobor P; Hummer M; Kemmler G; Kohnen R; Volavka J
    Arch Gen Psychiatry; 2003 May; 60(5):458-64. PubMed ID: 12742866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic statistics for clinicians: 1. Hypothesis testing.
    Guyatt G; Jaeschke R; Heddle N; Cook D; Shannon H; Walter S
    CMAJ; 1995 Jan; 152(1):27-32. PubMed ID: 7804919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reporting of noninferiority trials was incomplete in trial registries.
    Dekkers OM; Soonawala D; Vandenbroucke JP; Egger M
    J Clin Epidemiol; 2011 Sep; 64(9):1034-8. PubMed ID: 21444195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninferiority testing beyond simple two-sample comparison.
    Tsong Y; Chen WJ
    J Biopharm Stat; 2007; 17(2):289-308. PubMed ID: 17365225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
    Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
    Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypotheses and type I error in active-control noninferiority trials.
    Chen G; Wang YC; Chi GY
    J Biopharm Stat; 2004 May; 14(2):301-13. PubMed ID: 15206528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring rare serious adverse events from a new treatment and testing for a difference from historical controls.
    Fay MP; Huang CY; Twum-Danso NA
    Clin Trials; 2007; 4(6):598-610. PubMed ID: 18042569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninferiority hypotheses and choice of noninferiority margin.
    Ng TH
    Stat Med; 2008 Nov; 27(26):5392-406. PubMed ID: 18680173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized clinical trial design for assessing noninferiority when superiority is expected.
    Freidlin B; Korn EL; George SL; Gray R
    J Clin Oncol; 2007 Nov; 25(31):5019-23. PubMed ID: 17971602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the lower predictive bound approach for noninferiority clinical trials with binary data.
    Liu Q; Li Y
    J Biopharm Stat; 2014; 24(6):1225-38. PubMed ID: 25036815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Likelihood ratio and a Bayesian approach were superior to standard noninferiority analysis when the noninferiority margin varied with the control event rate.
    Kim MY; Xue X
    J Clin Epidemiol; 2004 Dec; 57(12):1253-61. PubMed ID: 15617951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tests of noninferiority via rate difference for three-arm clinical trials with placebo.
    Tang ML; Tang NS
    J Biopharm Stat; 2004 May; 14(2):337-47. PubMed ID: 15206531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing noninferiority in a three-arm trial using the Bayesian approach.
    Ghosh P; Nathoo F; Gönen M; Tiwari RC
    Stat Med; 2011 Jul; 30(15):1795-808. PubMed ID: 21520456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to demonstrate similarity by using noninferiority and equivalence statistical testing in radiology research.
    Ahn S; Park SH; Lee KH
    Radiology; 2013 May; 267(2):328-38. PubMed ID: 23610094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothesis testing in the "gold standard" design for proving the efficacy of an experimental treatment relative to placebo and a reference.
    Koch A; Röhmel J
    J Biopharm Stat; 2004 May; 14(2):315-25. PubMed ID: 15206529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.